Taipei, Taiwan – 11/08/2025 — Andaman Medical’s affiliate, Nord Pacific Medical has been invited by the Institute for Biotechnology and Medicine Industry (IBMI) to serve as a strategic partner for the Taiwan Healthcare+ Expo 2025.
Through this partnership, Nord Pacific Medical will advocate for international medical device and IVD manufacturers, in collaboration with Andaman Medical.This partnership positions Nord Pacific Medical as a trusted bridge, helping to connect global innovators with meaningful opportunities in Taiwan’s healthcare ecosystem. This reinforces Nord Pacific Medical’s ongoing mission to guide manufacturers through complex regulatory pathways and develop effective go-to-market strategies across Asia.
“We are delighted to welcome Nord Pacific Medical as a strategic partner for the Taiwan Healthcare+ Expo 2025,” said Dr. Chung-Liang Chien, CEO at IBMI. “Their deep understanding of international regulatory environments and strong network of global MedTech innovators will support our mission of making Taiwan a regional hub for advanced healthcare technologies.”
The Taiwan Healthcare+ Expo 2025 is expected to host around 650 exhibitors across more than 2,000 booths and attract over 130,000 professional visitors. The event will reinforce Taipei’s role as a leading hub for healthcare innovation in the Asia-Pacific region. Beyond the main exhibition, the Expo features matchmaking sessions and investor forums, offering tangible opportunities for technology transfer, procurement, and cross-border partnerships. It has become an essential fixture for organizations aiming to scale within the region’s rapidly expanding silver economy and healthtech landscape.
Nord Pacific Medical is an affiliate of Andaman Medical, a pioneer in regulatory services for medical devices and IVDs since 2013. Combined, both Nord Pacific Medical and Andaman Medical operate eleven offices across Asia and is recognized for its expertise in helping manufacturers achieve market entry and compliance in one of the world’s fastest-growing healthcare regions.
“This collaboration with IBMI is a natural extension of our core services,” said May Tan, Chief Brand and Marketing Officer at Nord Pacific Medical. “We’re proud to support global manufacturers seeking to navigate Taiwan’s regulatory and commercial landscape and bring innovative solutions to the patients who need them.”
If you’re considering participation or would like to explore how this opportunity could benefit your business, please don’t hesitate to reach out to Michelle Wang mwang@rbmp.org.tw or visit https://expo.taiwan-healthcare.org/en/about.php for more details.
About Nord Pacific Medical
Nord Pacific Medical helps medical device and IVD manufacturers successfully enter and grow in East Asia. With expertise in regulatory strategy, market access, and commercialization, the company enables manufacturers to focus on innovation while it navigates the complexity of bringing products to market.
In addition to supporting international clients, Nord Pacific Medical also assists local Taiwanese manufacturers in expanding globally. By fostering cross-border collaboration, the company advances its broader mission to ensure patients across Asia gain timely access to high-quality, innovative medical technologies.
To learn more, visit https://nordpacificmed.com.
